Alkermes PLC (ALKS)
24.10
-0.49
(-1.99%)
USD |
NASDAQ |
May 08, 16:00
Alkermes Cash from Financing (TTM): -284.97M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -284.97M |
December 31, 2023 | -289.71M |
September 30, 2023 | -13.49M |
June 30, 2023 | -15.27M |
March 31, 2023 | -8.17M |
December 31, 2022 | -1.574M |
September 30, 2022 | -4.482M |
June 30, 2022 | -3.237M |
March 31, 2022 | -1.897M |
December 31, 2021 | 29.07M |
September 30, 2021 | 32.10M |
June 30, 2021 | 30.96M |
March 31, 2021 | 17.70M |
December 31, 2020 | -2.171M |
September 30, 2020 | -0.274M |
June 30, 2020 | 2.744M |
March 31, 2020 | 0.878M |
December 31, 2019 | 6.765M |
September 30, 2019 | 3.03M |
June 30, 2019 | 0.688M |
March 31, 2019 | 2.64M |
December 31, 2018 | -1.62M |
September 30, 2018 | 4.823M |
June 30, 2018 | 5.402M |
March 31, 2018 | 7.571M |
Date | Value |
---|---|
December 31, 2017 | 4.084M |
September 30, 2017 | -2.911M |
June 30, 2017 | -59.97M |
March 31, 2017 | -68.34M |
December 31, 2016 | -58.17M |
September 30, 2016 | -57.06M |
June 30, 2016 | 23.24M |
March 31, 2016 | 32.32M |
December 31, 2015 | 40.89M |
September 30, 2015 | 70.43M |
June 30, 2015 | 65.41M |
March 31, 2015 | 55.81M |
December 31, 2014 | 308.76M |
September 30, 2014 | 299.06M |
June 30, 2014 | 291.79M |
March 31, 2014 | 313.00M |
September 30, 2013 | 56.67M |
June 30, 2013 | -30.30M |
March 31, 2013 | -45.04M |
December 31, 2012 | -58.07M |
September 30, 2012 | -65.82M |
June 30, 2012 | 453.21M |
March 31, 2012 | 464.85M |
December 31, 2011 | 463.04M |
September 30, 2011 | 462.84M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-289.71M
Minimum
Dec 2023
32.10M
Maximum
Sep 2021
-25.07M
Average
-0.924M
Median
Cash from Financing (TTM) Benchmarks
Endo International PLC (DELISTED) | -604.63M |
Jazz Pharmaceuticals PLC | -332.02M |
Medtronic PLC | -6.981B |
Perrigo Co PLC | -196.90M |
Iterum Therapeutics PLC | 1.034M |